1. Search Result
Search Result
Results for "

Silybin

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

8

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N0779A
    Silybin
    2 Publications Verification

    Silibinin

    Apoptosis Inflammation/Immunology Cancer
    Silybin is a flavonolignan isolated from milk thistle (Silybum marianum) seeds. Silybin induces apoptosis and exhibits hepatoprotective, antioxidant, anti-inflammatory, anti-cancer activity .
    Silybin
  • HY-N7046

    Silibinin B

    Amyloid-β Neurological Disease Cancer
    Silybin B (Silibinin B), a flavonolignan separated from Silybum marianum, has anti-tumor activity. Silybin B is the most potent antifibrillogenic and anti-oligomeric component of silymarin and proposes it as a promising anti Alzheimer’s disease agent candidate .
    Silybin B
  • HY-13748
    Silybin A
    5+ Cited Publications

    Silibinin A

    Autophagy Reactive Oxygen Species Cancer
    Silybin A (Silibinin A), an effective anti-cancer and chemopreventive agent, has been shown to exert multiple effects on cancer cells, including inhibition of both cell proliferation and migration.
    Silybin A
  • HY-139637

    Silibinin (mixture of Silybin A and Silybin B)

    Apoptosis Cancer
    (±)-Silybin is the racemate of Silybin (HY-N0779A). Silybin induces apoptosis and exhibits hepatoprotective, antioxidant, anti-inflammatory, anti-cancer activity .
    (±)-Silybin
  • HY-N12360A

    Others Others
    2,3-Dehydrosilybin B is an enantiomer formed by the oxidation of the natural flavonolignans silybin A .
    2,3-Dehydrosilybin B
  • HY-N0779AR

    Apoptosis Inflammation/Immunology Cancer
    Silybin (Standard) is the analytical standard of Silybin. This product is intended for research and analytical applications. Silybin is a flavonolignan isolated from milk thistle (Silybum marianum) seeds. Silybin induces apoptosis and exhibits hepatoprotective, antioxidant, anti-inflammatory, anti-cancer activity .
    Silybin (Standard)
  • HY-N7046R

    Amyloid-β Neurological Disease Cancer
    Silybin B (Standard) is the analytical standard of Silybin B. This product is intended for research and analytical applications. Silybin B (Silibinin B), a flavonolignan separated from Silybum marianum, has anti-tumor activity. Silybin B is the most potent antifibrillogenic and anti-oligomeric component of silymarin and proposes it as a promising anti Alzheimer’s disease agent candidate .
    Silybin B (Standard)
  • HY-13748R

    Autophagy Reactive Oxygen Species Cancer
    Silybin A (Standard) is the analytical standard of Silybin A. This product is intended for research and analytical applications. Silybin A (Silibinin A), an effective anti-cancer and chemopreventive agent, has been shown to exert multiple effects on cancer cells, including inhibition of both cell proliferation and migration.
    Silybin A (Standard)
  • HY-114661

    PROTAC Linkers Cancer
    m-PEG4-Tos is a derivative of silybin ethers, extracted from patent CN105037337A (compound III-b). m-PEG4-Tos is a PEG-based PROTAC linker can be used in the synthesis of Silymarin (HY-W043277) .
    m-PEG4-Tos
  • HY-135090

    PROTAC Linkers Cancer
    Tos-PEG8-m is a derivative of silybin ethers, extracted from patent CN105037337A (compound III-d). Tos-PEG8-m is a PEG-based PROTAC linker can be used in the synthesis of Silymarin (HY-W043277) .
    m-PEG8-Tos
  • HY-W042501

    PROTAC Linkers Cancer
    m-PEG5-Tos is a derivative of silybin ethers, extracted from patent CN105037337A (compound III-c). m-PEG5-Tos is a PEG-based PROTAC linker can be used in the synthesis of Silymarin (HY-W043277) .
    m-PEG5-Tos